Yoshikazu Ikoma

8PUBLICATIONS
20CO-AUTHORS
Haematological tumoursAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 30, 2026
Tracheostomy Before Polatuzumab Vedotin-Containing Therapy for Airway-Threatening Cervical Diffuse Large B-Cell Lymphoma: A Case Report of Two Patients.

|Aug 11, 2026
HIV-Associated Diffuse Large B-Cell Lymphoma Treated With Outpatient Pola-R-CHP Without Antiretroviral Therapy Modification: A Case Report.

|Dec 26, 2025
Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High-Dose Cytarabine-Based Chemotherapy as Second-Line Treatments for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Yoshikazu Ikoma, Nobuhiko Nakamura, Junichi Kitagawa

|Nov 27, 2025
Donor-Derived T-Cell Redirection With Epcoritamab Achieving Complete Response After Early Post-Allo-HSCT Relapse of DLBCL.

Yoshikazu Ikoma, Yuto Kaneda, Ryoma Shimazu

|Nov 24, 2025
A Comparison of the Risk of Viral Load Blips in Human Immunodeficiency Virus Patients on Two-Drug Versus Three-Drug Antiretroviral Regimens.

Kimihiro Yamaguchi, Masashi Ishihara, Yoshikazu Ikoma

|Apr 21, 2025
Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML.

Yoshikazu Ikoma, Nobuhiko Nakamura, Yuto Kaneda

Pageof 2

Frequent Collaborators

6 joint publications

Nobuhiko Nakamura

5 joint publications

Masahito Shimizu

3 joint publications

Nobuhiro Kanemura

1 joint publications

Hiroyuki Takamori